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  Transduction	  and	  Amplification	  through	  Enzyme-­‐Triggered	  
Ligand	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  and	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  Goggins,a	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  J.	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  Anneke	  Lubbena	  and	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Signal	   transduction	   and	   signal	   amplification	   are	  both	   important	  mechanisms	  used	  within	  biological	   signalling	  pathways.	  
Inspired	   by	   this	   process,	   we	   have	   developed	   a	   signal	   amplification	   methodology	   that	   utilises	   the	   selectivity	   and	   high	  
activity	  of	  enzymes	   in	  combination	  with	   the	   robustness	  and	  generality	  of	  an	  organometallic	   catalyst,	  achieving	  a	  hybrid	  
biological	  and	  synthetic	  catalyst	  cascade.	  A	  proligand	  enzyme	  substrate	  was	  designed	  to	  selectively	  self-­‐immolate	   in	  the	  
presence	   of	   the	   enzyme	   to	   release	   a	   ligand	   that	   can	   bind	   to	   a	  metal	   pre-­‐catalyst	   and	   accelerate	   the	   rate	   of	   a	   transfer	  
hydrogenation	  reaction.	  Enzyme-­‐triggered	  catalytic	  signal	  amplification	  was	  then	  applied	  to	  a	  range	  of	  catalyst	  substrates	  
demonstrating	  that	  signal	  amplification	  and	  signal	  transduction	  can	  both	  be	  achieved	  through	  this	  methodology.	  
Introduction	  
In	   nature,	   living	   organisms	   utilise	   signal	   transduction	   and	  
signal	   amplification	   for	   selective	   and	   amplified	   chemical	  
responses	   towards	   particular	   stimuli.1	   These	   powerful	  
systems	  are	  used	  for	  a	  number	  of	  purposes,	  such	  as	  visual	  
excitation,2	   blood	   clotting,3	   and	   biosignalling.4	   Typically,	  
these	   biological	   responses	   are	   realised	   through	   enzyme	  
cascade	   mechanisms.5	   Naturally,	   the	   high	   signal	  
amplification	   and	   rapid	   response	   times	   of	   these	   systems	  
have	   inspired	   the	   development	   of	   a	   range	   of	   versatile,	  
synthetic	  signal	  amplification	  systems	  for	  stimuli-­‐responsive	  
materials,6	   supramolecular	   signalling,7	   and	   sensing.8	   With	  
regard	   to	   the	   latter,	   approaches	   towards	   signal	  
amplification	   for	   sensing	   vary	   tremendously	   with	  
nanomaterials,9	   conjugated	   polymers,10	   and	  
supramolecular	   aggregates,11	   all	   being	   successfully	  
incorporated	   into	   analyte	   detection	   methodologies	   and	  
achieving	  low	  limits	  of	  detection.	  Recently,	  the	  introduction	  
of	   self-­‐immolative	   dendrimers,12	   has	   propelled	   the	  
development	   of	   small	   molecule-­‐based	   signal	   amplification	  
protocols.13	  In	  particular,	  the	  dendritic	  chain	  reaction	  (DCR)	  
developed	   by	   Sella	   and	   Shabat,14	   and	   the	   two-­‐component	  
system	   developed	   by	   Baker	   and	   Phillips,15	   have	   both	  
demonstrated	   autoinductive	   and	   autocatalytic	   exponential	  
signal	   amplification	   for	   the	   detection	   of	   a	   number	   of	  
analytes.16	  Despite	  the	  high	  amplification	  achieved	  and	  the	  
thermal	   stability	   of	   the	   reagents,	   these	   methods	   suffer	  
from	  high	   background	   reactions	   due	   to	   reagent	   hydrolysis	  
and	   long	  reaction	  times.17	  As	  such,	   there	   is	  still	  a	  need	  for	  
stable	  and	   selective	   reagents	   that	   can	  provide	   rapid	   signal	  
amplification.	  
	   The	   ability	   of	   catalysts	   to	   generate	   multiple	   product	  
molecules	  without	  themselves	  being	  chemically	  altered	  has	  
seen	   them	   integrated	   as	   the	   amplifier	   component	   within	  
multiple	   signal	   amplification	   methodologies.18	   Signal	  
amplification	   by	   supramolecular	   catalysis	   (SAAC),19	   has	   by	  
far	   become	   the	  most	   popular	   catalytic	   approach	   to	   signal	  
amplification	  due	  to	  the	  plethora	  of	  supramolecular	  analyte	  
receptors	   and	   synthetic	   organometallic	   catalysts	   available	  
that	   can	   be	   combined	   to	   create	   an	   effective	   amplified	  
detection	   assay.20	   However,	   turnover	   numbers	   are	  
inadequate	  and	  the	  assays	  often	  require	  the	  use	  of	  organic	  
solvents	  under	  an	  inert	  atmosphere.	  Contrastingly,	  a	  range	  
of	   iridium-­‐based,	   water-­‐soluble	   organometallic	   complexes	  
have	  been	  synthesised	  and	  shown	  to	  perform	  a	  number	  of	  
organic	   transformations	   “in-­‐“	   or	   “on-­‐water”.21	   Iridium-­‐
catalysed	   transfer	   hydrogenation	   in	   particular,	   is	   of	  
significant	   interest	   due	   to	   its	   low	   catalytic	   loading,	   fast	  
reaction	  times	  and	  high	  substrate	  conversion.22	  To	  the	  best	  
of	  our	  knowledge,	  these	  outstanding	  catalyst	  attributes	  are	  
yet	   to	   be	   harnessed	   for	   signal	   amplification	   within	   as	  
sensing	   methodology.	   Herein,	   we	   describe	   an	   enzyme-­‐
triggered	   iridium-­‐catalysed	   transfer	   hydrogenation	   for	  
signal	  transduction	  and	  amplification.	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Fig.	  1	  Signal	  amplification	  concept	   through	  enzyme-­‐triggered	   ligand	  release	  
and	  subsequent	  ligand-­‐accelerated	  organometallic	  catalysis.	  
Results	  and	  discussion	  
Concept	  
Inspired	  by	  biosignalling	  enzyme	  cascades,	  we	  designed	  an	  
enzyme-­‐activated	   synthetic	   catalyst	   cascade	   that	   could	   be	  
used	   for	   signal	   transduction	   and	   signal	   amplification	  
purposes	   (Fig.	   1).	   In	   principle,	   this	   would	   combine	   the	  
selectivity	   and	   high	   activity	   of	   an	   enzyme	   plus	   add	   the	  
control	   and	   scope	  of	   a	   synthetic	   catalyst.	   To	  gain	  proof	  of	  
concept,	   we	   initially	   looked	   into	   identifying	   an	   efficient	  
catalyst	  that	  we	  could	  employ	  as	  both	  our	  signal	  transducer	  
and	  signal	  amplifier.	  Also,	  we	  required	  a	  catalyst	  that	  could	  
be	   selectively	   switched	   on	   in	   the	   presence	   of	   an	   enzyme.	  
One	  catalytic	  system	  that	  we	  believed	  fulfilled	  these	  criteria	  
was	   an	   iridium-­‐based	   transfer	   hydrogenation	   catalyst,	  
which	   has	   been	   shown	   to	   efficiently	   reduce	   aldehydes	   in	  
aqueous	  media.22	  Not	  only	  this,	  but	  the	  addition	  of	  a	  ligand	  
was	  shown	  to	  increase	  the	  turnover	  frequency	  (TOF)	  of	  the	  
catalyst	   600-­‐	   fold,	   which	   we	   could	   potentially	   manipulate	  
for	  	  catalyst	  activation.	  
	   To	   begin	   our	   investigation,	   we	   looked	   to	   use	   an	  
electroactive	   aldehyde	   as	   the	   catalyst	   substrate	   as	   this	  
would	   allow	   reaction	  progress	   to	  be	  monitored	   ‘real-­‐time’	  
through	   simple	   electrochemical	   analysis	   without	   the	   need	  
for	   compound	   extraction	   or	   isolation.	   The	   stability	   of	  
ferrocene	   in	   aqueous	   media,	   its	   compatibility	   with	  
biological	   components	   and	   its	   favourable	   electrochemical	  
properties	   made	   ferrocenecarboxaldehyde	   1	   an	   obvious	  
initial	   choice.23	   	   Electrochemical	   analysis	   of	   1,	   and	   its	  
corresponding	   reduced	   product,	   ferrocenemethanol	   2,	  
using	   differential	   pulse	   voltammetry	   (DPV),	   revealed	   that	  
aldehyde	   1	   and	   alcohol	   2	   have	   considerably	   different	  
oxidation	   potentials	   (ΔEox	   ≈	   300	   mV)	   (Fig.	   2).	   As	   no	   peak	  
overlap	   was	   observed,	   peak	   integration	   could	   be	   used	   to	  
calculate	  reaction	  conversion	  allowing	  reaction	  progress	  to	  
be	   monitored	   using	   ratiometric	   electrochemical	   analysis.	  
Ratiometric	   sensing	   has	   the	   benefit	   of	   obtaining	   reaction	  
conversions	   without	   internal	   or	   external	   standards,	   and	  
also	   minimises	   errors	   associated	   with	   sampling	   and	  
electrode	   or	   instrument	   variations.	   Thus,	   the	   reaction	  
conversion	   of	   the	   transfer	   hydrogenation	   reaction	   can	   be	  
calculated	  using	  eqn.	  (1).	  
	   Pleasingly,	  when	  the	   literature	  conditions	  were	  applied	  
to	   ferrocenecarboxaldehyde	   1,	   the	   product,	  
ferrocenemethanol	   2,	   was	   isolated	   in	   71%	   yield.	   By	  
increasing	  the	  catalytic	  loading	  and	  introducing	  an	  enzyme-­‐
compatible,	   water-­‐miscible	   co-­‐solvent	   to	   improve	   the	  
solubility	  of	   the	   substrate,	  quantitative	  yield	  was	  achieved	  
in	  just	  30	  minutes	  at	  room	  temperature.	  In	  order	  to	  further	  
improve	   catalytic	   activity	   under	   the	   optimised	   conditions	  
we	   synthesised	  and	   tested	  a	   range	  of	   ligands	  with	   varying	  
aryl	  substituents	  (ESI†).	  Only	  mesityl-­‐derivative	  L4	  provided	  
any	  improvement	  over	  the	  previously-­‐used	  tosyl-­‐derivative	  
and	   was	   subsequently	   used	   in	   all	   further	   studies.	  
Importantly,	   in	   the	   absence	   of	   any	   ligand,	   minimal	  
conversion	  was	  observed,	  highlighting	  the	   importance	  of	  a	  
ligand	   in	  order	  to	  achieve	  high	  catalytic	  activity	   (Table	  S1).	  
Thus,	   we	   hypothesised	   that	   a	   programmed,	   selective	  
release	   of	   the	   ligand	   would	   accelerate	   the	   transfer	  
hydrogenation	  reaction	  in	  the	  presence	  of	  an	  enzyme.	  
	  
	  
Fig.	  2	  Differential	  pulse	  voltammogram	  obtained	   for	  a	  mixture	  of	  0.25	  mM	  
ferrocenecarboxaldehyde	  1	  and	  0.25	  mM	  ferrocenemethanol	  2.	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Entry	   Ligand	   Conversiona	  
1	   L11	   2%	  
2	   L12	   2%	  
3	   L13	   <1%	  
4	   L14	   2%	  
5	   L15	   0%	  
6	   L4	   >99%	  
7	   L16	   34%	  
8	   L17	   6%	  
9	   L18	   0%	  
10	   L19	   0%	  
11	   L20	   7%	  
12	   L21	   <1%	  
13	   L22	   2%	  
a	  Determined	  by	  ratiometric	  electrochemical	  analysis	  
	  
Scheme	  2	  Synthetic	  route	  to	  PL1.	  
Ligand	  functionalisation	  studies	  towards	  proligand	  design	  
Enzyme-­‐triggered	  compound	  release	   is	   typically	  associated	  
with	  prodrug	  methodologies,	  where	  active	  pharmaceutical	  
ingredients	   are	   manipulated	   with	   enzyme-­‐responsive	  
functional	   groups	   to	   improve	   their	   physical	   properties	   as	  
well	   as	   their	   potency.24	   We	   therefore	   reasoned	   that	   we	  
could	   combine	   an	   enzyme-­‐cleavable	   trigger	  moiety	  with	   a	  
self-­‐immolative	   linker	   to	   design	   a	   proligand	   which	   would	  
selectively	   release	  our	  optimised	   ligand	   in	   the	  presence	  of	  
an	   enzyme.	   To	   achieve	   a	   successful	   proligand,	   we	   first	  
required	   further	   information	   regarding	   the	   essential	  
components	   and	   the	   limitations	   of	   the	   ligand.	   Therefore,	  
we	  synthesised	  (ESI†)	  another	  set	  of	  ligand	  derivatives	  and	  
tested	  them	  under	  the	  optimised	  reaction	  conditions	  (Table	  
1).	  
	   Ethylenediamine,	   along	   with	   its	   mono-­‐	   and	   di-­‐
methylated	  derivatives	  (Table	  1,	  entries	  1‒4)	  were	  all	  found	  
to	   be	   ineffective	   ligands	   under	   these	   conditions.	   Also,	  
tetramethylethylenediamine	   (Table	   1,	   entry	   5)	  was	   shown	  
to	   completely	   inhibit	   the	   reaction.	   Expectedly,	   the	   best-­‐
performing	   ligand	   deduced	   from	   the	   optimisation,	   mono-­‐
mesityl	   sulfonamide	   L4	   (Table	   1,	   entry	   6),	   delivered	  
quantitative	   conversion	   in	   30	   minutes,	   confirming	   that	   a	  
sulfonamide	   is	   required	   for	   a	   high	   reaction	   rate.	  
Methylation	   at	   the	   primary	   amine	   position	   of	   L4	   (Table	   1,	  
entry	  7),	  leads	  to	  a	  drop-­‐off	  in	  conversion	  but	  interestingly,	  
does	  not	   inhibit	   the	   reaction	  completely.	  Since	  a	  proton	   is	  
still	   available	   at	   this	   position	   to	   activate	   the	   carbonyl	  
towards	  attack	  of	  the	  hydride,	  this	  result	  corresponds	  with	  
a	   typical	   transfer	   hydrogenation	   reaction	   mechanism.25	  
Methylation	   of	   the	   sulfonamide	   of	   L4	   (Table	   1,	   entry	   8)	  
however,	   leads	   to	   a	   significantly	   greater	   drop-­‐off	   in	  
conversion	  as	  functionalisation	  at	  this	  position	  removes	  the	  
acidic	  sulfonamide	  proton	  required	  for	   iridium	   insertion	  to	  
form	   the	   active	   catalyst.	   Unsurprisingly	   therefore,	   both	  
dimethyl	   derivatives	   of	   L4	   (Table	   1,	   entries	   9‒10)	  
completely	  inhibit	  the	  transfer	  hydrogenation	  reaction	  with	  
no	   conversion	   at	   all	   observed.	  Clearly,	   as	   functionalisation	  
at	  the	  primary	  amine	  position	  of	  L4	  was	  enough	  to	  prevent	  
ligand	   acceleration	   of	   the	   catalyst,	   we	   next	   looked	   at	  
ligands	   with	   alternative	   functionality	   at	   this	   position.	  
Protecting	   the	   primary	   amine	   position	   as	   a	   carbamate	  
(Table	   1,	   entries	   11‒13),	   was	   indeed	   found	   to	   have	   a	  
detrimental	   impact	   on	   reaction	   conversion.	   Interestingly,	  
benzyl	   carbamate	   derivatives	   L21	  and	   L22	   exhibit	  minimal	  
conversion	   in	   the	   transfer	  hydrogenation	   reaction,	   leading	  
us	   to	   believe	   that	   we	   could	   release	   ligand	   L4	   through	   a	  
quinone-­‐methide	  elimination	  mechanism.26	  
Proligand	  synthesis	  and	  mechanistic	  studies	  
Consequently,	   proligand	   PL1	   was	   designed	   (Scheme	   1)	  
containing	   a	   benzyl	   carbamate	   linkage	   along	   with	   a	  
phosphate	   functional	   group	   as	   the	   enzyme-­‐cleavable	  
trigger.	   A	   phosphate	   trigger	   enables	   PL1	   to	   be	   an	  
appropriate	   enzyme	   substrate	   for	   alkaline	   phosphatase	  
















L11, R1 = R2 = R3 = R4 = H
L12, R1 = Me, R2 = R3 = R4 = H
L13, R1 = R2 = Me, R3 = R4 = H
L14, R1 = R3 = Me, R2 = R4 = H
L15, R1 = R2 = R3 = R4 = Me
L4, R5 = R6 = R7 = H
L16, R5 = Me, R6 = R7 = H
L17, R5 = R6 = H, R7 = Me
L18, R5 = R6 = Me, R7 = H























L20, R8 = tBu
L21, R8 = Bn
L22, R8 = 4-MeOBn
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robustness	   and	   inexpensive	   cost.27	   ALP	   is	   also	   a	   target	   of	  
interest	   since	   abnormal	   serum	   levels	   can	   be	   used	   to	  
preliminarily	  diagnose	  diseases	  such	  as	  bone	  disease,28	  liver	  
dysfunction,29	  breast	  and	  prostatic	  cancer,30	  and	  diabetes.31	  
Moreover,	  ALP	  is	  commonly	  used	  as	  an	  enzyme	  label	  within	  
enzyme-­‐linked	   immunosorbent	   assays	   (ELISA)	   due	   to	   its	  
ease	   of	   antibody	   conjugation	   allowing	   for	   this	   signal	  
amplification	   methodology	   to	   be	   applied	   to	   sensitive	  
protein	  detection.32	  
	   The	  mechanism	  we	  propose	  for	  this	  signal	  amplification	  
methodology	   is	   illustrated	   in	   Scheme	   1.	   Initially,	   selective	  
dephosphorylation	  of	  PL1	  by	  the	  enzyme	  ALP	  should	  occur	  
and	  the	  resulting	  phenol	  intermediate	  would	  be	  unstable	  in	  
the	   alkaline	   buffered	   conditions	   preferred	   by	   the	   enzyme.	  
Subsequent	   1,6-­‐elimination	   should	   then	   take	   place	  
releasing	  carbon	  dioxide,	  quinone	  methide	  3	  and	  ligand	  L4.	  
Complexation	  of	  the	  newly	  released	  ligand	  with	  the	  iridium	  
precatalyst	   would	   generate	   the	   active	   transfer	  
hydrogenation	  catalyst	  4	  and	  an	  accelerated	  conversion	  of	  
aldehyde	  to	  alcohol	  should	  then	  be	  observed.	  
	   The	  synthesis	  of	  PL1	   (Scheme	  2)	  was	  achieved	  through	  
1,1’-­‐carbonyldiimidazole	   (CDI)	   coupling	   of	   previously	  
reported	   benzyl	   alcohol	   5,33	   and	   L4	   to	   afford	   diallyl-­‐
protected	   carbamate	   6.	   Allyl	   deprotection	   was	   then	  
performed	   through	   the	  use	  of	  a	  polymer-­‐bound	  palladium	  
catalyst	  under	  reductive	  conditions	  and	  subsequent	  sodium	  
salt	  formation	  furnished	  proligand	  PL1	  in	  64%	  overall	  yield.	  
Once	  isolated,	  PL1	  was	  found	  to	  be	  an	  air-­‐stable	  solid	  which	  
can	   be	   stored	   in	   a	   vial	   at	   room	   temperature	   for	   several	  
months	  with	  any	  sign	  of	  degradation.	  
	   	  	  To	  determine	  whether	  proligand	  PL1	   is	  an	  appropriate	  
substrate	  for	  ALP,	  PL1	  was	  subjected	  to	  a	  buffered	  solution	  
containing	  ALP	  and	   the	   interaction	  monitored	  by	   31P	  NMR	  
(Figure	   2).	   Over	   time,	   PL1	   was	   shown	   to	   be	   completely	  
consumed	   by	   the	   enzyme	   and	   simultaneously,	   the	  
appearance	   of	   another	   peak	   corresponding	   to	   the	  
phosphate	   anion,	   indicated	   that	   enzyme-­‐catalysed	  
hydrolysis	  of	  the	  reagent	  was	   indeed	  occurring.	   In	  another	  
experiment,	   this	   time	   in	   the	   absence	   of	   the	   enzyme,	   the	  
phosphate	   peak	   was	   not	   observed	   showing	   that	   PL1	   is	  
stable	   towards	   background	   hydrolysis	   and	   that	   phosphate	  
cleavage	  occurs	  selectively	   in	   the	  presence	  of	   the	  enzyme.	  
Due	  to	  the	  need	  for	  a	  proton-­‐saturated	  buffer	  solution	  and	  
the	  poor	  solubility	  of	  the	   ligand	  L4	   in	  an	  aqueous	  solution,	  
we	   were	   unable	   to	   detect	   the	   free	   ligand,	   or	   any	  
elimination	  products	  by	  1H	  NMR.	  
	   In	  order	  to	  detect	  the	  elimination	  products,	  we	  studied	  
the	   reaction	   using	   direct	   infusion	   Electrospray	   Time-­‐of-­‐
Flight	   mass	   spectrometry	   (ESI-­‐UHR-­‐TOF	   MS,	   negative	   ion	  
mode).	  Initially,	  an	  aqueous	  solution	  of	  PL1	  was	  monitored	  
over	   a	   ten	  minute	   time-­‐frame	  and	   in	   this	   period,	   only	   the	  
ion	  corresponding	  to	  the	  [M−H]−	  of	  PL1	  was	  observed,	  and	  
no	   ion	   corresponding	   to	   ligand	   L4	   was	   seen	   (Supporting	  
information	  -­‐	  Figure	  S2).	  This	  confirms	  the	  stability	  of	  PL1	  to	  
hydrolysis.	   Then,	   immediately	   after	   the	   addition	   of	   a	  
solution	   of	   ALP,	   the	   appearance	   of	   the	   [M−H]−	   ion	  
corresponding	   to	   L4	   is	   seen	   and	   this	   ion	   is	   shown	   to	  
increase	  with	  intensity	  over	  time	  (Figure	  3).	  Concomitantly,	  
the	  enzyme	  substrate	   ion	  decreases	   in	   intensity,	   indicating	  
that	   enzyme-­‐catalysed	   consumption	   of	   PL1	   and	  
simultaneous	   production	   of	   L4	   is	   occurring.	   Additionally,	  
[M−H]−	   ions	   relating	   to	   eliminated	   linker	   3	   and	   4-­‐
hydroxybenzyl	  alcohol,	  a	  result	  of	  quinone	  methide	  3	  being	  
trapped	   by	   water,	   are	   also	   observed	   and	   intensities	   for	  
these	   ions	   increase	   slowly	   over	   time	   (Supporting	  
information	  -­‐	  Figure	  S3).	  Over	  the	  course	  of	  the	  experiment,	  
the	   [M−H]−	   ion	   for	   the	   phenol	   intermediate	   was	   never	  
observed.	  This	  suggests	  that	  elimination	  to	  L4	  and	  3	  occurs	  
rapidly	   under	   the	   reaction	   conditions.	   Together,	   this	   data	  
confirms	   that	   both	   dephosphorylation	   of	   PL1	   and	  
subsequent	   elimination	   to	   release	   L4	   occurs	   selectively	   in	  
the	   presence	   of	   enzyme,	   which	   supports	   the	   enzyme-­‐
triggered	  catalyst	  activation	  mechanism	  we	  propose.	  
	  
	  
Fig.	  2	  Stacked	  31P	  NMR	  plots	  of	  PL1	  after	  addition	  of	  ALP.	  
	  
	  
Fig.	   3	   Reaction	   profile	   of	   PL1	   after	   addition	   of	   ALP	   monitored	   by	   mass	  
spectrometry.	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Scheme	  1	  Proposed	  mechanism	  for	  enzyme-­‐triggered	  ligand	  release	  and	  subsequent	  ligand-­‐accelerated	  transfer	  hydrogenation	  
Enzyme-­‐triggered	  catalysis	  
Having	  established	  that	   ligand	  release	  occurs	  selectively	  as	  
a	  direct	  result	  of	  enzyme	  activity,	  a	  number	  of	  background	  
reactions	   were	   performed	   to	   determine	   if	   catalyst	  
activation	  is	  attributed	  to	  the	  combination	  of	  the	  presence	  
of	   the	  enzyme	  and	   the	  enzyme	   substrate	   (Table	  2).	   In	   the	  
presence	  of	  just	  the	  enzyme	  and	  no	  PL1	  (Table	  2,	  entry	  1),	  
no	   conversion	   of	   1	   to	   2	   was	   observed	   showing	   that	   any	  
ligand-­‐like	   amino	   acid	   side-­‐chains	   on	   the	   enzyme	   itself	   or	  
any	   enzyme	   additives	   such	   as	   amino	   alcohol-­‐derived	  
stabilisers	  do	  not	  contribute	  to	  any	  undesired	  reduction.	  In	  
the	   absence	   of	   the	   enzyme,	   a	   satisfactorily	   low	   yield	   of	  
ferrocenemethanol	  2	  was	  obtained	   in	   the	  presence	  of	   just	  
the	   proligand	   (Table	   2,	   entry	   2).	   Gratifyingly,	   in	   the	  
presence	   of	   both	   the	   enzyme	   and	   the	   proligand	   (Table	   2,	  
entry	   3),	   a	   near	  quantitative	   yield	  was	  obtained	  which	  we	  
attribute	   to	   enzyme-­‐triggered	   ligand	   release	   and	   ligand-­‐
accelerated	  catalytic	  transfer	  hydrogenation.	  
	   With	   catalyst	   activity	   shown	   only	   to	   be	   activated	   by	  
both	   the	   enzyme	   and	   the	   enzyme	   substrate,	   we	   next	  
wanted	   to	   optimise	   the	   signal	   amplification	   cascade	   using	  
ratiometric	   electrochemical	   analysis	   to	   monitor	   the	  
cascade.	   Prior	   to	   this	   however,	   electrochemically-­‐derived	  
reaction	   profiles	   were	   needed	   for	   the	   active	   catalytic	  
species	   in	   order	   to	   determine	   the	   lowest	  
catalytic	   loading	   required	   to	   obtain	   full	   conversion	   in	   the	  
shortest	  amount	  of	  time.	  As	  such,	  ferrocenecarboxaldehyde	  
1	   was	   exposed	   to	   different	   catalytic	   loadings	   and	   the	  
reaction	   was	   sampled	   every	   3	   minutes	   (Figure	   4).	   At	   a	  
catalyst	   loading	   of	   0.5	   mol%,	   only	   ≈50%	   conversion	   was	  
observed	  after	  30	  minutes.	  By	  doubling	  the	  catalyst	  loading	  
to	  1	  mol%,	  quantitative	  conversion	  was	  able	  to	  be	  obtained	  
within	   the	   same	   timeframe.	  Doubling	   the	   catalytic	   loading	  
further	   to	   2	   mol%	   enabled	   quantitative	   conversion	   to	   be	  
achieved	  in	  less	  than	  6	  minutes.	  
	   Encouraged	   by	   the	   efficiency	   of	   the	   transfer	  
hydrogenation	  of	  1	  at	  the	  higher	  catalyst	  loading,	  we	  set	  to	  
electrochemically	   monitor	   enzyme	   activity	   over	   time	  
(Figure	   5).	   Pleasingly,	   in	   the	   presence	   of	   high	  
concentrations	   of	   ALP,	   conversion	   of	   1	   to	   2	   was	   indeed	  
observed.	   The	   sigmoidal	   shape	   of	   the	   conversion	   curves	  
indicate	   a	   slow	   catalyst-­‐activation	   induction	   period	   is	  
apparent	   until	   a	   sufficient	   number	   of	   iridium	   complexes	  
have	   been	   activated	  which	   leads	   to	   a	   pseudo-­‐exponential	  
increase	   in	   conversion.	   A	   number	   of	   signal	   amplification	  
methodologies	   previously	   reported	   exhibit	   sigmoidal	  
reaction	   profiles	   that	   are	   indicative	   of	   an	   exponential-­‐like	  
mechanism	   being	   in	   effect.14a,15a,34	   Importantly,	   in	   the	  
absence	  of	  the	  enzyme,	  a	  minimal	  background	  reaction	  was	  
observed	   showing	   that	   activation	   of	   the	   catalytic	   cascade	  
occurs	   selectively.	   This	   further	   enhances	   the	   potential	   of	  
this	   methodology	   since	   no	   protection,	   separation	   or	  
manipulation	   of	   the	   reagents	   is	   required	   to	   achieve	  
successful	  activation	  of	  the	  catalytic	  cascade.	  
	   To	   improve	   the	   efficiency	   of	   the	   signal	   amplification	  
cascade	   further,	   we	   increased	   the	   temperature	   of	   the	  
system	  to	  coincide	  with	  the	  optimum	  working	  temperature	  
of	   the	   enzyme.32	   This	  would	   not	   only	   increase	   the	   rate	   of	  
PL1	  consumption	  but	  also	   increase	  the	  rate	  of	  the	  transfer	  
hydrogenation	   reaction,	   thus	   leading	   to	   a	  much	   improved	  
signal-­‐amplified	   response.	   Indeed,	   at	   these	   elevated	  
temperatures,	  much	  greater	  conversions	  were	  observed	   in	  
comparison	   to	   the	   conversions	   obtained	   for	   the	   same	  
enzyme	   concentration	   at	   room	   temperature	   (Figure	   6).	   A	  
high	   concentration	   of	   ALP	   at	   37	   °C	   allows	   for	   quantitative	  
conversion	   of	   the	   transfer	   hydrogenation	   reaction	   to	  
obtained	   within	   15	   minutes.	   Good	   conversions	   are	   also	  
seen	   at	   lower	   enzyme	   concentrations	   indicating	   both	   the	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excellent	   sensitivity	   and	   good	   dynamic	   range	   of	   the	  
catalytic	   cascade.	   However,	   the	   increase	   in	   temperature	  
also	   leads	   to	   an	   increase	   in	   the	   background	   rate,	  which	   is	  
expected	   since	   ligand-­‐less	   iridium	  pre-­‐catalysts	   are	   known	  
to	   catalyse	   the	   transfer	   hydrogenation	   reaction.22a	   Using	  
the	   conversions	   obtained	   under	   these	   conditions	   after	   3	  
minutes,	  a	  calibration	  curve	  was	  plotted	  (ESI†).	  From	  this,	  a	  
limit	  of	  detection	  for	  this	  methodology	  was	  calculated	  to	  be	  
7.6	  pM	  after	  a	  reaction	  time	  3	  minutes	  which	  is	  comparable	  
with	   that	   of	   redox	   cycling-­‐based	   amplification	  
methodologies	  for	  rapid	  electrochemical	  ALP	  detection.35	  









Entry	   Proligand	   ALP	   Yielda	  
1	   0	  mol%	   100	  UmL-­‐1	   0%	  
2	   2	  mol%	   0	  UmL-­‐1	   4%	  
3	   2	  mol%	   100	  UmL-­‐1	   95%	  
a	  Isolated	  Yield	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Fig.	   4	   Electrochemically-­‐determined	   reaction	   profiles	   under	   different	  
catalytic	  loadings	  of	  active	  catalyst	  8.	  	  
	  
	  
Fig.	   5	   Electrochemically-­‐determined	   reaction	   profiles	   under	   different	  








Fig.	   6	   Electrochemically-­‐determined	   reaction	   profiles	   under	   different	  
concentrations	  of	  ALP	  at	  37	  °C.	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Entry	   Product	   Conversiona	  
	   	   ALP	  	  
	   	   0	  UmL-­‐1	   25	  UmL-­‐1	  
1b	  
	  
10%	   >99%	  
2b	  
	  
2%	   77%	  
3b	  
	  
2%	   95%	  
4c	  
	  
4%	   >99%	  
5c	  
	  
20%	   >99%	  
6c	  
	  
21%	   >99%	  
7b	  
	  
11%	   >99%	  
8b	  
	  
13%	   >99%	  
9b	  
	  
14%	   >99%	  
10b	  
	  
26%	   >99%d	  








Entry	   Product	   Conversiona	  
	   	   ALP	  
	   	   0	  UmL-­‐1	   25	  UmL-­‐1	  
	   	   	   	  
11b	  
	  
24%	   >99%	  
12b	  
	  
	  8%	   75%	  
a	  Conversion	  determined	  by	  1H	  NMR.	  b	  Reaction	  conditions:	  0.25	  mol%	  
[Ir(cp*Cl2)2],	  0.5	  mol%	  PL1,	  25	  UmL-­‐1	  ALP,	  0.5	  mmol	  R−CHO,	  5	  eq.	  NaOOCH,	  1	  
mL	  EtOH,	  1	  mL	  pH	  9.8	  CO32-­‐	  buffer,	  37	  °C,	  30	  mins.	  c	  Reaction	  conditions:	  0.25	  
mol%	  [Ir(cp*Cl2)2],	  0.5	  mol%	  PL1,	  25	  UmL-­‐1	  ALP,	  1	  mmol	  R−CHO,	  5	  eq.	  
NaOOCH,	  2	  mL	  EtOH,	  2	  mL	  pH	  9.8	  CO32-­‐	  buffer,	  37	  °C,	  30	  mins.	  d	  combined	  
conversion	  of	  20	  (75%)	  and	  1,4-­‐benzenedimethanol	  (25%).	  
	  
Substrate	  scope	  
We	  next	  wanted	  to	  determine	   if	  catalyst	  cascade	  could	  be	  
applied	   to	   the	   enzyme-­‐triggered	   reduction	   of	   aldehydes	  
other	   than	   ferrocenecarboxaldehyde.	   Therefore,	   the	  
optimised	  conditions	  were	  then	  directly	  applied	  to	  a	  range	  
of	   different	   aldehydes	   (Table	   3).	   Initially,	   we	   looked	   at	  
catalyst	   substrates	   that	   could	   also	   be	   used	   to	   monitor	  
reaction	  progress,	  and	  therefore	  enzyme	  activity,	  by	  means	  
other	   than	   electrochemistry.	   First,	   we	   evaluated	  
fluorophore-­‐containing	  aldehydes	   (Table	  3,	  entries	  1‒3)	  as	  
this	   would	   allow	   signal	   transduction	   from	   enzyme	   activity	  
to	   fluorescence	   to	   be	   obtained.	   Pleasingly,	   all	   fluorescent	  
aldehydes	   tested	   delivered	   good	   to	   quantitative	  
conversions	   in	   the	   presence	   of	   ALP,	   whilst	   maintaining	   a	  
satisfactorily	   low	   background	   in	   its	   absence.	   Next,	   we	  
investigated	   fluorine-­‐containing	   aromatic	   aldehydes	   (Table	  
3,	  entries	  4‒6),	  which	  would	  enable	  19F	  NMR	  to	  be	  used	  to	  
monitor	   reaction	   progress.	   Again,	   good	   to	   quantitative	  
conversions	   were	   obtained	   using	   these	   benzaldehydes.	  
Electron-­‐withdrawing	   substituents	   upon	   the	   aromatic	   ring	  
(Table	   3,	   entries	   5‒6)	   were	   found	   to	   over-­‐activate	   the	  
aldehyde	  towards	  hydride	  attack	  and	  a	  subsequent	  increase	  
in	   background	   reaction	   is	   observed.	   In	   contrast,	   electron-­‐
donating	   groups	   (Table	   3,	   entries	   7‒8)	   were	   able	   to	  
suppress	  this	  background	  reaction.	  Interestingly,	  when	  a	  di-­‐
aldehyde	  was	  used	  as	  the	  catalyst	  substrate	  (Table	  3,	  entry	  
10),	   the	  mono-­‐hydrogenated	  product	  was	   found	   to	  be	   the	  
major	   product	   over	   the	   di-­‐hydrogenated	   product	   in	   a	   3:1	  
ratio.	   Aliphatic	   aldehydes	   (Table	   3,	   entry	   11)	   are	   also	  
tolerated,	   but	   an	   undesirably	   high	   background	   was	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observed	   which	   we	   attribute	   to	   the	   high	   solubility	   of	   the	  
substrate	   in	   the	   reaction	   medium.	   Cinnamaldehydes	   are	  
also	  reduced	  efficiently	   (Table	  3,	  entry	  12)	   in	  the	  presence	  
of	  ALP	  with	  no	  alkene	  reduction	  being	  observed.	  
	   On	  the	  whole,	  signal	  transduction	  from	  enzyme	  activity	  
to	   a	   range	   of	   output	   signals	   was	   successfully	   performed	  
whilst	  maintaining	  sufficiently	  low	  signals	  in	  the	  absence	  of	  
ALP.	  Despite	  this,	  we	  are	  currently	  investigating	  methods	  to	  
nullify	   the	   background	   rate	   to	   improve	   the	   signal-­‐to-­‐noise	  
ratio.	   Also,	   the	   application	   of	   this	   catalyst	   cascade	   to	   the	  
detection	   of	   other	   enzymes,	   as	   well	   as	   proteins	   via	   ELISA	  
techniques,	  is	  currently	  underway.	  
Conclusions	  
In	  summary,	  we	  have	  successfully	  developed	  a	  biosynthetic	  
signal	   transduction	   and	   signal	   amplification	   methodology	  
by	  utilising	  the	  selectivity	  and	  high	  activity	  of	  an	  enzyme,	  in	  
combination	  with	  a	  water-­‐tolerant	  organometallic	  catalyst.	  
Through	   simple	  manipulation	  of	   the	  proligand	   trigger,	   this	  
methodology	   can	   be	   applied	   towards	   the	   detection	   of	   a	  
number	   of	   different	   enzymes	   as	  well	   as	   other	   analytes	   of	  
interest.	   We	   have	   also	   shown	   that	   selective	   catalyst	  
activation	  by	  an	  enzyme	  can	  be	  used	  to	  reduce	  a	  range	  of	  
aldehydes	  allowing	  the	  amplification	  cascade	  to	  be	  tailored	  
to	   the	   desired	   signal	   output.	   In	   principle,	   this	   technology	  
could	   easily	   be	   used	   as	   a	   general	   signal	   amplification	  
strategy	   for	   improving	   the	   sensitivity	   of	   enzyme	  detection	  
assays	  and,	  by	  extension,	  protein	  detection	  assays	  through	  
enzyme-­‐linked	   immunosorbent	   assay	   (ELISA)	   protocols.	  
Additionally,	   the	  ability	   for	   the	  system	  to	  process	  a	  simple	  
input	   signal	   and	   convert	   it	   into	   an	   amplified	   signal	   output	  
lends	   itself	   towards	   molecular	   computing	   applications	   as	  
well	  as	  stimuli-­‐responsive	  materials.	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